在使用迪克洛芬雅克后接受治疗抗凝固药的年轻成年人的急性STEMI
Naeem Hasanfatta1, Naveed Ahmed2, Debabrata Dash2
1Department of Cardiology, Aster Jubilee Medical Complex, Dubai, United Arab Emirates.
Journal of the Saudi Heart Association
|March 2, 2026
概括
非类固醇抗炎药物 (NSAIDs) 像狄克洛菲纳克可以引起严重的血栓事件,如ST升高心肌梗塞 (STEMI),即使在接受治疗抗凝药的患者中也是如此. 谨慎的NSAID处方是必不可少的,因为抗凝药不能防止这些血小板驱动的风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 急性冠状动脉综合征 (ACS) 在年轻人中很少见.
- 一名34岁的男性进行了机械心肌置换 (MVR),患上前侧ST升高心肌梗塞 (STEMI).
- 这种情况发生在开始用迪克洛芬雅克后不久的治疗抗凝药 (INR 3.17) 之后.
研究的目的:
- 突出使用抗凝固药的患者NSAID使用的血栓风险.
- 强调谨慎的NSAID处方的重要性.
- 为了证明治疗INR不能预防血小板驱动的血栓事件.
主要方法:
- 一个病人的病例报告呈现异常症状.
- 前部STEMI的诊断通过心电图和冠状动脉血管学证实.
- 成功通过皮肤进行透光冠状动脉血管整形 (PTCA) 治疗左前下降动脉 (LAD) 阻塞.
主要成果:
- 患者在中部LAD动脉中经历了100%的血栓性阻塞.
- 没有记录过高凝血状态或动脉样硬化病史.
- 在症状发作前9天开始使用迪克洛菲纳克被确定.
结论:
- 使用NSAID,包括迪克洛菲纳克,具有显著的血栓形成风险.
- 适当的抗凝血用阿诺库马罗没有防止STEMI.
- 治疗性INR水平不会防止NSAID诱导的血小板驱动的血栓事件.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Venous Thrombosis III: Interprofessional Care
426
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426
Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care
349
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
563
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
563


